- (a) An OTP shall perform, or have performed, drug screens of clients as described in this section.
- (b) All new clients shall have a minimum of a drug screen upon admission and randomly every week thereafter for the first 3 months of treatment.
- (c) After the first 3 months of treatment, all clients shall have a minimum of one drug screen performed randomly every month.
(d) All required drug screens shall include, at a minimum, the following substances or their metabolites:
- (1) Opiates;
- (2) Methadone;
- (3) Buprenorphine;
- (4) Amphetamines;
- (5) Cocaine;
- (6) Benzodiazepines;
- (7) Cannabis; and
- (8) Methamphetamine.
- (e) A drug screen shall be considered positive for illicit substances only if the substance identified is not being used under the supervision of and as directed by a licensed practitioner.
- (f) When a client disputes the results of a positive drug screen, the screen shall only be considered positive after confirmatory testing by a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory.
Source. #12476, eff 2-16-18